Letter from the Editor

Dear Reader,

What would a “grand cru” from Burgundy have in common with a major oncology congress? Both have remarkable vintage years – which will be remembered for long – and others are less extraordinary, even though of sound quality and careful assembly – still worth your palate, or eyes and ears. We were spoiled by a remarkable succession of groundbreaking ESMO congresses these last years. I’m afraid this year was not a “millésime”– even though, as always, of high quality. I am sure that you will still find enough new research results and practice-relevant information to keep you satisfied.

I hope you will also be satisfied with our picks of relevant presentations. To be able to include a maximum of information, we decided to wrap up some presentations in shorter form (“More highlights in..”). We hope you appreciate the effort.

Please enjoy this year’s ESMO Medicom Conference Report.

 

Yours, sincerely,

Dr Stefan Rauh

 

Biography

Dr Stefan Rauh is currently working as oncologist/haematologist in the oncology department of Centre Hospitalier Emile Mayrisch, Esch, Luxembourg. He is mainly involved in clinical work but also in research and teaching activities and is interested in public policy and international cooperation projects in oncology. He is a member of the ESMO Practicing Oncologist’s Working Group since 2011 (chair 2014–2018), member of the ESMO Public Policy Committee, and has been an ESMO Executive Board member in 2015–2016. He is interested in survivorship of cancer patients
and has published a clinician’s handbook on this topic: Survivorship Care for Cancer Patients.

 

Conflict of Interest Statement: Nothing to declare.



Posted on 4 November 2024